Stock A206650 EUBIOLOGICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
13,400 KRW -1.69% Intraday chart for EuBiologics Co., Ltd. +10.29% +16.83%
29/01 Zimbabwe launches door-to-door cholera vaccination campaign RE
2023 Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial
CI
EuBiologics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Eubiologics Co., Ltd. Announces Phase Iii Clinical Trial Ind Approval of Eucorvac-19, Covid-19 Vaccine Candidate, in South Korea
CI
EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea
CI
Global Health Investment Fund I, LLC, managed by Global Health Investment Advisors, LLC acquired 6.19% stake in EuBiologics Co., Ltd..
CI
EuBiologics Co., Ltd. has completed an IPO in the amount of KRW 19.2 billion.
CI
EuBiologics Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A206650 Stock
  4. News EuBiologics Co., Ltd.
  5. Highlights